Key result
The Tirone David procedure for bicuspid aortic valves demonstrated 100% 30-day survival, with 45 of 51 patients alive at follow-up and no cases of severe aortic regurgitation.
Why the study?
Short and midterm outcomes needed to be evaluated for aortic valve-sparing root replacement in patients with bicuspid aortic valves.
What are the short and midterm outcomes of the Tirone David procedure in adults with bicuspid aortic valves?
Cohort (n=51)
What are the short and midterm outcomes of the Tirone David procedure in adults with bicuspid aortic valves?
The Tirone David procedure is a safe and effective option for aortic root replacement in younger patients with bicuspid aortic valves, with excellent survival and low rates of severe aortic regurgitation at midterm follow-up.
Answers are grounded in this paper and cite their sources.
Supports Tirone procedure safety in select BAV patients; leaves open long-term durability versus replacement.
Background We evaluated short and midterm outcomes with use of aortic valve-sparing root replacement to treat bicuspid aortic valves (BAVs). Methods From December 2007 to January 2022, all patients with BAVs who underwent aortic root replacement using Tirone's procedure were included. This study based on department database information for retrospective and follow-up data. Results Among 51 adults undergoing aortic root replacement using Tirone's procedure, the mean age was 47.4 ± 12.5 years, and most were men (92.2%). Three presented with a dysmorphic syndrome and one had Marfan's syndrome. All patients were alive at 30 days, and as of January 2022, 45 were alive, two were lost to follow-up, and there were four noncardiac deaths. Two patients had infectious endocarditis and needed a Bentall's procedure. One patient had a double biologic valve replacement in the context of severe mitral insufficiency with moderate aortic stenosis at 4.5 years postprocedure. Echocardiographic follow-up showed a left ventricular ejection fraction of 63 ± 7% (n = 36), Vmax 2 ± 0.6 m/s (n = 17), and a mean gradient of 9.4 ± 5.4 mmHg (n = 27). No patients had grade 3 or 4 aortic regurgitation, one patient had grade 2, and four had grade 1. Conclusion Tirone's procedure is an option for BAV surgery, with good safety and outcomes, especially in younger patients.
No takes yet. Share an insight, caveat, or question.
Pujos et al. (2022) conducted a cohort in Bicuspid aortic valves (BAVs) (n=51). Tirone David procedure (aortic valve-sparing root replacement) was evaluated on Short and midterm outcomes. The Tirone David procedure for bicuspid aortic valves demonstrated 100% 30-day survival, with 45 of 51 patients alive at follow-up and no cases of severe aortic regurgitation.
Synapse has enriched 10 related papers. Consider them for comparative context: